KOE · 115450.KQ
HLB Therapeutics Co.,Ltd.
₩2,505-₩55 (-2.15%)
HLB Therapeutics Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.78% below the high.
Loading market information…
KOE · 092040.KQ · KRW
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:25 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Amicogen, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.8% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Amicogen, Inc.’s forward annual dividend is ₩100 per share, paid annual. The forward yield is 10.93% at the quoted price. Future payments can change.
Dividend payment history is currently unavailable.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Amicogen, Inc.’s next earnings report is currently expected on Dec 14, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Amicogen, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Amicogen, Inc. is an industrial biotechnology firm established in 2000, with its headquarters located in Jinju-si, South Korea, conducting business both domestically and globally. The company engineers and supplies a diverse range of specialized enzymes, such as CX and SP, that serve critical functions across the pharmaceutical, food, chemical, and energy sectors. In addition to enzymes, Amicogen produces innovative bio-ingredients, including N-acetylglucosamine for enhancing skin moisture and joint well-being; pinitol/D-chiro-inositol; collagen peptides and tripeptides aimed at promoting skin and general health; chitoslim and chitosan oligosaccharides; various lactic acid bacteria; as well as fucoxanthin, curezyme, food enzymes, and bamboo salt. Furthermore, the company markets its own consumer lines, K-nutra for health-related products and KeyClean for disinfectants, and also provides protein purification resins.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:46 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩2,505-₩55 (-2.15%)
HLB Therapeutics Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.78% below the high.
₩5,810-₩110 (-1.86%)
JETEMA, Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.49% below the high.
₩5,250-₩100 (-1.87%)
EASY BIO,Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.67% below the high.
₩3,680+₩60 (+1.66%)
Helixmith Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 63.05% below the high.
₩13,420-₩660 (-4.69%)
Anterogen.Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 78.28% below the high.
₩10,860-₩90 (-0.82%)
Macrogen, Inc.’s quoted price sits in the lower half of its reported 52-week range, 48.04% below the high.
₩3,000+₩30 (+1.01%)
MedPacto, Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.32% below the high.
₩2,160-₩5 (-0.23%)
Genexine, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.09% below the high.
